PHK
TTPH

Point72 Hong Kong’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Point72 Hong Kong’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-175
Closed -$12K – 1318
2018
Q2 		$12K Buy
+175
New +$12.4K ﹤0.01% 642
2017
Q4 		– Sell
-28
Closed -$4K – 1200
2017
Q3 		$4K Buy
+28
New +$3.75K ﹤0.01% 607

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Hong Kong's TTPH Position: Q3 2018 in Review

Point72 Hong Kong sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2018, closing a stake of 175 shares — an estimated $12K sold.

Point72 Hong Kong first reported a position in TTPH in Q3 2017 and held it in 2 quarters. The position peaked at $12K in Q2 2018. 92 funds tracked by Wall St. Rank hold TTPH as of Q3 2018.

  • Point72 Hong Kong reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Point72 Hong Kong sold 175 Tetraphase Pharmaceuticals, Inc. shares in Q3 2018, an estimated $12K.
  • Point72 Hong Kong first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Point72 Hong Kong's Tetraphase Pharmaceuticals, Inc. position peaked at $12K in Q2 2018.
  • 92 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2018.

Based on Point72 Hong Kong's 13F filing for Q3 2018, filed 14 Nov 2018.